Kenneth M. Boy
28Patents
8h-index
48Co-inventors
71Inventor score
Filing activity: Dec 9, 2003 → Apr 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7173004B2 | Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus | Human Necessities | 47 | Expired |
| US8637525B2 | Compounds for the reduction of beta-amyloid production | Chemistry; Metallurgy | 37 | Active |
| US8486952B2 | Compounds for the reduction of β-amyloid production | Chemistry; Metallurgy | 30 | Active |
| US9308236B2 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Emerging Cross-Sectional Technologies | 24 | Active |
| US9879046B2 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Emerging Cross-Sectional Technologies | 13 | Active |
| US6933308B2 | Aminoalkyl thiazole derivatives as KCNQ modulators | Chemistry; Metallurgy | 10 | Expired |
| US9850283B2 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Physics | 9 | Active |
| US9809625B2 | Immunomodulators | Chemistry; Metallurgy | 8 | Active |
| US9856292B2 | Immunomodulators | Emerging Cross-Sectional Technologies | 8 | Active |
| US10633419B2 | Immunomodulators | Emerging Cross-Sectional Technologies | 6 | Active |
| US7388007B2 | Gamma-lactams as beta-secretase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US7408071B2 | N-aryl pyrrolidine derivatives as beta-secretase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7902218B2 | Substituted tetrahydroisoquinolines as β-secretase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8349880B2 | Bicyclic compounds for the reduction of beta-amyloid production | Chemistry; Metallurgy | 3 | Active |
| US11103605B2 | PET-imaging immunomodulators | Chemistry; Metallurgy | 3 | Active |
| US8637523B2 | Compounds for the reduction of beta-amyloid production | Chemistry; Metallurgy | 2 | Active |
| US11358988B2 | Immunomodulators | Emerging Cross-Sectional Technologies | 2 | Active |
| US7049309B2 | 3-Thia-4-arylquinolin-2-one potassium channel modulators | Chemistry; Metallurgy | 1 | Expired |
| US11952434B2 | Immunomodulators | Emerging Cross-Sectional Technologies | 0 | Active |
| US7273866B2 | 2-aryl thiazole derivatives as KCNQ modulators | Chemistry; Metallurgy | 0 | Expired |
| US7145013B2 | 3-thia-4-arylquinolin-2-one derivatives | Chemistry; Metallurgy | 0 | Expired |
| US9833454B2 | Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production | Human Necessities | 0 | Active |
| US7002015B2 | 3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants | Chemistry; Metallurgy | 0 | Expired |
| US7179920B2 | 3-thia-4-arylquinolin-2-one derivatives | Chemistry; Metallurgy | 0 | Expired |
| US7981913B2 | Isophthalates as beta-secretase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.